---
title: "Insider Move: Apnimed Director Makes Bold New Investment"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/294769081.md"
description: "Apnimed Director Paul Sekhri purchased 12,500 shares worth $200,000 on August 3, 2026, signaling confidence in the company. Apnimed's IPO was priced at $16.00 per share for 12 million shares, upsized from 10 million and set at the high end of the range, indicating strong investor demand for its novel oral therapies for sleep-related breathing disorders."
datetime: "2026-08-04T02:08:20.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/294769081.md)
  - [en](https://longbridge.com/en/news/294769081.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/294769081.md)
generator: "portal-rs"
---

# Insider Move: Apnimed Director Makes Bold New Investment

New insider activity at Apnimed, Inc. ( (APMD) ) has taken place on August 3, 2026.

Director Paul Sekhri of Apnimed, Inc. has significantly increased his stake in the company by purchasing 12,500 shares of its stock in a recent transaction. The total value of this investment amounts to $200,000, signaling a notable show of confidence in Apnimed’s future prospects from within its leadership.

Apnimed Inc. saw notable attention as its IPO was priced at $16.00 per share for 12M shares, with the deal upsized from 10M and set at the high end of the $14.00–$16.00 range. The increased deal size and top-range pricing suggest strong investor demand and confidence in Apnimed’s late-stage pipeline of novel oral therapies for sleep-related breathing disorders, driving recent trading interest.

**More about Apnimed, Inc.**

**YTD Price Performance:** 0%

**Average Trading Volume:** 3,444,667

**Current Market Cap:** $0

### Related Stocks

- [APMD.US](https://longbridge.com/en/quote/APMD.US.md)

## Related News & Research

- [Apnimed director Paul J. Sekhri acquires $200,000 in common shares](https://longbridge.com/en/news/294730912.md)
- [Avalyn Announces Multiple Presentations at the European Respiratory Society International Congress 2026 | AVLN Stock News](https://longbridge.com/en/news/296823873.md)
- [Vivos Opens New Henderson Sleep Testing and Treatment Center](https://longbridge.com/en/news/296656579.md)
- [Can Komzifti's Early Adoption Support Kura Oncology's Next Phase Of Growth?](https://longbridge.com/en/news/296928079.md)
- [10:31 ETLiver Cirrhosis Market to Expand Significantly Through 2036, Driven by Emerging Therapies and Increasing Disease Burden | DelveInsight](https://longbridge.com/en/news/296802956.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**